AIDS in the era of antiretroviral therapy: Changes in incidence rates and predictors of AIDS among people living with HIV under clinical care in Germany, a cohort study 1999–2018

This study examined the incidence rates and predictive utility of established prognostic factors for the progression to AIDS among people living with HIV under clinical care.

[1]  N. Bannert,et al.  The impact of regional socioeconomic deprivation on the timing of HIV diagnosis: a cross-sectional study in Germany , 2022, BMC Infectious Diseases.

[2]  H. Stellbrink,et al.  Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017 , 2020, Infection.

[3]  R. Holzman,et al.  Trends in Mortality From Human Immunodeficiency Virus Infection, 1984-2016: An Autopsy-Based Study. , 2020, Archives of pathology & laboratory medicine.

[4]  L. Egede,et al.  HIV and cardiovascular disease in sub-Saharan Africa: Demographic and Health Survey data for 4 countries , 2019, BMC Public Health.

[5]  A. Whiteside,et al.  Twenty Years Of Antiretroviral Therapy For People Living With HIV: Global Costs, Health Achievements, Economic Benefits. , 2019, Health affairs.

[6]  Hansjakob Furrer,et al.  Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study , 2019, The Lancet.

[7]  P. Schommers,et al.  Antiretroviral treatment indications and adherence to the German-Austrian treatment initiation guidelines in the German ClinSurv HIV Cohort between 1999 and 2016 , 2018, Infection.

[8]  H. Lane,et al.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. , 2015, The New England journal of medicine.

[9]  R. Salamon,et al.  A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. , 2015, The New England journal of medicine.

[10]  A. Uusküla,et al.  Adherence to Antiretroviral Medications Among Persons Who Inject Drugs in Transitional, Low and Middle Income Countries: An International Systematic Review , 2015, AIDS and Behavior.

[11]  J. van Lunzen,et al.  From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany , 2015, BMC Public Health.

[12]  P. Harrigan,et al.  Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting , 2014, PloS one.

[13]  W. El-Sadr,et al.  When to start ART in Africa--an urgent research priority. , 2013, The New England journal of medicine.

[14]  Timothy R Sterling,et al.  An internationally generalizable risk index for mortality after one year of antiretroviral therapy , 2013, AIDS.

[15]  Martha Sajatovic,et al.  Clinical Prediction Models , 2013 .

[16]  R. Scheufele,et al.  The risk of AIDS-defining events is decreasing over time in the German HIV-1 Seroconverter Cohort , 2012, BMC Infectious Diseases.

[17]  D. Matysiak-Klose,et al.  Cohort profile: the German ClinSurv HIV project – a multicentre open clinical cohort study supplementing national HIV surveillance , 2011, HIV medicine.

[18]  G. Breton.  [Immune reconstitution inflammatory syndrome]. , 2011, Bulletin de l'Academie nationale de medecine.

[19]  Matthew Hickman,et al.  HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage , 2010, The Lancet.

[20]  C.J.H. Mann,et al.  Clinical Prediction Models: A Practical Approach to Development, Validation and Updating , 2009 .

[21]  E. Steyerberg.  Clinical Prediction Models , 2008, Statistics for Biology and Health.

[22]  J. Sterne,et al.  Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies , 2007, AIDS.

[23]  Jintanat Ananworanich,et al.  Predictors of disease progression in HIV infection: a review , 2007, AIDS research and therapy.

[24]  Jonathan AC Sterne,et al.  Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies , 2002, The Lancet.

[25]  M. Chesney,et al.  The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  R. Chaisson,et al.  Natural history of HIV infection in the era of combination antiretroviral therapy. , 1999, AIDS.

[27]  J. Margolick,et al.  Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. , 1998, JAMA.

[28]  J. Montaner,et al.  Injection Drug Use and HIV Antiretroviral Therapy Discontinuation in A Canadian Setting , 2012, AIDS and Behavior.